TELETRADER News
12/9/2021, 2:38 PM (Source: TeleTrader)
more TeleTrader news

Novavax-1.22%

110.99
Chart for: Novavax

EMA: Novavax jab approval possible by year end

The European Medicines Agency (EMA) said on Thursday that there is a possibility it will grant approval of the Novavax COVID-19 vaccine Nuvaxovid before the end of the year.

"When authorized, this vaccine will provide a new option for vaccinating people in the EU and globally," the agency stated.

The EMA started the review of the Novavax jab in November and noted it plans to conduct it "under an accelerated timeline."

Baha Breaking the News (BBN) / NP